Form 4 Tracker
Rafael Amado

President, Head of Global Oncology Research and Development · 4 filings · Latest: Apr 6, 2026

Zai Lab Ltd
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ZLAB
Rafael AmadoPresident, Head of Global Oncology Research and DevelopmentApr 6, 2026
Sale
$20.452,739$56.0K57,022
ZLAB
Amado RafaelApr 6, 2026
Proposed Sale
$20.452,739$56.0K
ZLAB
Rafael AmadoPresident, Head of Global Oncology Research and DevelopmentApr 2, 2026
Sale
$20.399,910$202.1K59,761
ZLAB
Rafael AmadoPresident, Head of Global Oncology Research and DevelopmentApr 2, 2026
Option Exercise
5,39169,671
ZLAB
Rafael AmadoPresident, Head of Global Oncology Research and DevelopmentApr 1, 2026
Option Exercise
19,52364,280
ZLAB
Amado RafaelApr 2, 2026
Proposed Sale
$20.399,910$202.1K
ZLAB
Rafael AmadoPresident, Head of Global Oncology Research and DevelopmentMar 13, 2026
Sale
$18.632,957$55.1K44,757
ZLAB
Rafael AmadoPresident, Head of Global Oncology Research and DevelopmentMar 12, 2026
Option Exercise
5,32347,714
ZLAB
Amado RafaelMar 13, 2026
Proposed Sale
$18.632,957$55.1K
ZLAB
Rafael AmadoPresident, Head of Global Oncology Research and DevelopmentMar 3, 2026
Sale
$17.3810,000$173.8K42,391
ZLAB
Amado RafaelMar 3, 2026
Proposed Sale
$17.3810,000$173.8K
ZLAB
Amado RafaelDec 31, 2025
Proposed Sale
$17.4310,787$188.0K
ZLAB
Amado RafaelAug 8, 2025
Proposed Sale
$35.003,000$105.0K
ZLAB
Amado RafaelApr 4, 2025
Proposed Sale
$33.113,029$100.3K
ZLAB
Amado RafaelApr 2, 2025
Proposed Sale
$35.897,541$270.7K
ZLAB
Amado RafaelMar 17, 2025
Proposed Sale
$38.413,000$115.2K
ZLAB
Amado RafaelDec 31, 2024
Proposed Sale
$26.287,583$199.3K